HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Expert Panel Tentatively OKs Silicate Ingredients With Crystalline Caveats; Full Meeting Results

Executive Summary

The Cosmetic Ingredient Review’s Expert Panel for Cosmetic Ingredient Safety issued seven final assessments, six tentative reports and two insufficient data announcements at its virtual meeting on March 11-12.

You may also be interested in...



CIR Expert Panel Wraps Five Ingredient Safety Assessments, Finalizes 2022 Priorities

Meeting virtually on 13-14 September, Cosmetic Ingredient Review's independent expert panel issued final safety assessments for red algae, tea tree and three other ingredients/groups, as well as eight tentative reports and five insufficient data announcements. The group also finalized its review priorities for 2022.

US FDA Pushing For Cosmetics Industry Cooperation On Allergens, Other Priorities

The FDA’s Center for Food Safety and Applied Nutrition has a wish list for cosmetics reform legislation, but with Congress currently focused elsewhere, the agency is using its existing authority and resources to address cosmetics safety priorities while working to drive voluntary industry support.

SAI Lab Director ‘Elated’ By Federal Talc-Asbestos Testing Recs: ‘We Need To Be Aware That It’s There’

State-of-the-art testing approaches increasingly show that asbestos contamination of cosmetic talc is a concern worthy of the renewed attention it is receiving from federal agencies, says Scientific Analytical Institute’s research director Sean Fitzgerald.

Topics

UsernamePublicRestriction

Register

RS151143

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel